APEX is an athlete backed venture capital firm that invests in technology start-ups.
Portfolio
7
companies
CardiaTec Biosciences
CardiaTec Biosciences applies artificial intelligence to multiomic data for cardiovascular drug discovery.
Hexis
Hexis provides artificial intelligence driven nutritional planning for athletes.
Novoic
Novoic develops speech-based artificial intelligence algorithms for early neurological disease detection.
Output Sports
Output Sports builds wearable sensor technology for elite athletic performance tracking.
Upfront Diagnostics
Upfront Diagnostics develops rapid point-of-care blood tests for the rapid detection of strokes.
VividQ
VividQ develops holographic technology that converts standard consumer displays into immersive 3D screens.
Hermann Hauser
Advisor
Pooja Sikka
Venture Partner
Pooja brings venture capital and healthcare sector experience as a general partner across Meridian Health Ventures, Cross-Border Impact Ventures, and APEX Ventures, alongside her ongoing practice as an NHS general practitioner.
LinkedInGordon Euller
Partner
Gordon brings venture capital, management consulting, and medical operating experience. He previously served as a general partner at APEX Ventures and an engagement manager at McKinsey & Company.
LinkedInKoen Bosma
Head of Venture Capital
Koen brings venture capital and startup accelerator experience from his roles at APEX and Startupbootcamp. He also acts as an angel investor and board member for Drop.
LinkedInApex Capital and Uni.Fund backed the pre-A round alongside returning investors.
"In sports performance, only a handful of companies truly excel in addressing issues. Output Sports is among these select few. With their cutting-edge technology, they have successfully translated the science of sports into practical applications for the field."
The pre-seed round was backed by APEX and Sport Republic to support platform and infrastructure development.
"We are delighted to be collaborating with David and the entire Hexis team. In sports performance, proper nutrition plays a critical role, and Hexis stands out by making personalised nutritional guidance accessible to everyone. This kind of support will be crucial for athletes and sports organisations across the board. The Hexis team structure is impressive, with a CEO who has progressed from practitioner to PhD graduate to founder. The broader team of advisers, encompassing both academic and sports backgrounds, helps ensure that the team stays true to its mission of empowering athletes through nutrition. We can’t wait to embark on this journey and see the positive impact Hexis will have on the future of sports performance."
The seed round was led by APEX Ventures Medical Fund with backing from SBRI Healthcare and the Stroke Association.
"With this significant funding, we are poised to transform stroke diagnosis worldwide and make a tangible impact on patient care."
Nina Capital led the seed follow on round to support international growth and product scaling.
"Today’s seed funding exceeded our initial ask, showing the excitement building around Zetta Genomics’ game changing XetaBase data analytics platform. We now have the strategic headroom to configure for growth – to scale our technologies, enhance customer focus, and create a cycle of ongoing product innovation. This investment sees us one step closer to realising predictive, precision genomics – transforming research, healthcare and the lives of millions."
The pre-seed round was co-led by Laidlaw Scholars Ventures and APEX Ventures.
"Recent advances in artificial intelligence are generating novel ways to interpret multiomic data. I am excited to lead CardiaTec’s technology strategy to establish a new paradigm for understanding the pathophysiology of cardiovascular diseases."
